SCHEMBL30976447

SCHEMBL30976447

CCCCCCn1nc(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3[N+](=O)[O-])CC2)c2ccccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ MAPT P10636 7/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ ALDH1A1 P00352 6/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ CYP2D6 P10635 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ PHGDH O43175 4/20 0.43
▸ LMNA P02545 3/20 0.43
▸ GAA P10253 3/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CCR6 P51684 2/20 0.43
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30976418 0.94 MEN1 (0.51) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL30976428 0.86 MEN1 (0.55) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL30976384 0.82 MEN1 (0.53) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL30976325 0.80 LMNA (0.54) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL30976499 0.74 LMNA (0.56) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL30976411 0.72 TP53 (0.56) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL30976440 0.72 ALDH1A1 (0.50) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL28322333 0.70 MAPT (0.69) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL30976463 0.70 LMNA (0.58) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL30976302 0.70 LMNA (0.52) MEN1KMT2AMAPTNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 — — EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 — — WO disclosed
Send feedback